GALANTAMINE SR SCP galantamine (as hydrobromide) 8mg modified release capsules blister pack

País: Austràlia

Idioma: anglès

Font: Department of Health (Therapeutic Goods Administration)

ingredients actius:

galantamine hydrobromide, Quantity: 10.252 mg (Equivalent: galantamine, Qty 8 mg)

Disponible des:

Southern Cross Pharma Pty Ltd

Designació comuna internacional (DCI):

Galantamine hydrobromide

formulario farmacéutico:

Capsule, modified release

Composición:

Excipient Ingredients: magnesium stearate; ethylcellulose; titanium dioxide; hypromellose; Gelatin; microcrystalline cellulose

Vía de administración:

Oral

Unidades en paquete:

28

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

Galantamine is indicated for the treatment of mild to moderately severe dementia of the Alzheimer type

Resumen del producto:

Visual Identification: opaque white-white size 2 hard gelatin capsule containing one round biconvex tablet; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

Estat d'Autorització:

Licence status A

Data d'autorització:

2012-01-20